Search research articles
Contact Us
Filters
Showing results (121-130 of 276) with videos related to
Page
of 28
Sort By:
Leukemia & Lymphoma
|
May 6, 2014
Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome
Gail J Roboz, H Jean Khoury, Elias Jabbour, et al.
The Journal of Molecular Diagnostics : JMD
|
May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Leukemia & Lymphoma
|
December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia
G J Roboz, M A Knovich, R L Bayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Leukemia & Lymphoma
|
October 25, 2022
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, et al.
Leukemia
|
April 18, 2006
Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
G J Roboz, F J Giles, A F List, et al.
Leukemia & Lymphoma
|
June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial
Azra Raza, Joseph G Jurcic, Gail J Roboz, et al.
Leukemia & Lymphoma
|
February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
Gail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Cancer
|
October 6, 2018
Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions
David P Steensma, Andrew M Brunner, Amy E DeZern, et al.
Leukemia Research
|
June 15, 2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia
Francis J Giles, Alan F List, Michael Carroll, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 276) with videos related to
Sort By:
Page
of 28
Leukemia & Lymphoma
|
May 6, 2014
Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome
Gail J Roboz, H Jean Khoury, Elias Jabbour, et al.
The Journal of Molecular Diagnostics : JMD
|
May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Leukemia & Lymphoma
|
December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia
G J Roboz, M A Knovich, R L Bayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Leukemia & Lymphoma
|
October 25, 2022
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, et al.
Leukemia
|
April 18, 2006
Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
G J Roboz, F J Giles, A F List, et al.
Leukemia & Lymphoma
|
June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial
Azra Raza, Joseph G Jurcic, Gail J Roboz, et al.
Leukemia & Lymphoma
|
February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
Gail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Cancer
|
October 6, 2018
Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions
David P Steensma, Andrew M Brunner, Amy E DeZern, et al.
Leukemia Research
|
June 15, 2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia
Francis J Giles, Alan F List, Michael Carroll, et al.
Page
of 28